Alert-EmergencyArtboard 1

Urgent Provider Notification Regarding Ascension Cyber Event

April 2022 Test Bulletin

April 8, 2022

In their recent bulletin, Alverno Laboratories provided updates pertinent to healthcare providers. They implemented new FDA/CLSI MIC breakpoints for Piperacillin-Tazobactam (P/T) regarding Pseudomonas aeruginosa, enhancing precision in interpretation. Additionally, they introduced rapid PCR testing for positive blood cultures, utilizing the GenMark ePlex assay to expedite organism identification and resistance marker detection. These advancements aim to improve turnaround times and streamline diagnostic processes for better patient care. Furthermore, Alverno Laboratories announced a standardization effort for CBC test builds, discontinuing several test codes to enhance workflow efficiency. These updates reflect a commitment to providing high-quality laboratory services and staying at the forefront of diagnostic technologies.